Title
Multimorbidity: Not just for the west
Date Issued
01 January 2020
Access level
open access
Resource Type
review
Author(s)
CRÓNICAS, Centro de Excelencia en Enfermedades Crónicas
Publisher(s)
Ubiquity Press
Abstract
“A multimorbidity lens creates exciting opportunities to reconceptualise health and wellbeing in all its complexity. We need to improve health metrics to capture this complexity and strengthen health services to respond to it.”
Volume
15
Issue
1
Language
English
OCDE Knowledge area
Políticas de salud, Servicios de salud
Subjects
DOI
Scopus EID
2-s2.0-85090873105
PubMed ID
Source
Global Heart
ISSN of the container
22118160
Sponsor(s)
JJM acknowledges having received support from the Alliance for Health Policy and Systems Research (HQHSR1206660), the Bernard Lown Scholars in Cardiovascular Health Program at Harvard T.H. Chan School of Public Health (BLSCHP-1902), Bloomberg Philanthropies, FONDECYT via CIENCIACTIVA/CONCYTEC, British Council, British Embassy and the Newton-Paulet Fund (224-2018), DFID/MRC/Wellcome Global Health Trials (MR/M007405/1), Fogarty International Center (R21TW009982, D71TW010877), Grand Challenges Canada (0335-04), International Development Research Center Canada (IDRC 106887, 108167), Inter-American Institute for Global Change Research (IAI CRN3036), Medical Research Council (MR/P008984/1, MR/P024408/1, MR/P02386X/1), National Cancer Institute (1P20CA217231), National Heart, Lung and Blood Institute (HHSN268200900033C, 5U01HL114180, 1UM1HL134590), National Institute of Mental Health (1U19MH098780), Swiss National Science Foundation (40P740-160366), Wellcome (074833/Z/04/Z, 093541/Z/10/Z, 107435/Z/15/Z, 103994/Z/14/Z, 205177/Z/16/Z, 214185/Z/18/Z) and the World Diabetes Foundation (WDF15-1224).
AB has received funding from the BigData@Heart Consortium, under the Innovative Medicines Initiative-2 (116074, supported by the European Union’s Horizon 2020 programme and EFPIA [Chairs: DE Grobbee, SD Anker]). JJM, JRH, EF are investigators in the project ‘Multi-morbidity and infectious diseases: Strengthening links between the UK and Peru’ supported by an Institutional Links grant, grant IDs 413495350 (UK) and 223-2018 (Peru), under the UK-Peru partnership. The grant is funded by the UK Department for Business, Energy and Industrial Strategy and FONDECYT via CIENCIACTIVA/CONCYTEC and delivered by the British Council and the Newton-Paulet Fund. For further information, please visit www.newtonfund.ac.uk.
AB has received funding from the BigData@Heart Consortium, under the Innovative Medicines Initiative-2 (116074, supported by the European Union?s Horizon 2020 programme and EFPIA [Chairs: DE Grobbee, SD Anker]). JJM, JRH, EF are investigators in the project ?Multi-morbidity and infectious diseases: Strengthening links between the UK and Peru? supported by an Institutional Links grant, grant IDs 413495350 (UK) and 223-2018 (Peru), under the UK-Peru partnership. The grant is funded by the UK Department for Business, Energy and Industrial Strategy and FONDECYT via CIENCIACTIVA/CONCYTEC and delivered by the British Council and the Newton-Paulet Fund. For further information, please visit www.newtonfund.ac.uk. JJM acknowledges having received support from the Alliance for Health Policy and Systems Research (HQHSR1206660), the Bernard Lown Scholars in Cardiovascular Health Program at Harvard T.H. Chan School of Public Health (BLSCHP-1902), Bloomberg Philanthropies, FONDECYT via CIENCIACTIVA/CONCYTEC, British Council, British Embassy and the Newton-Paulet Fund (224-2018), DFID/MRC/Wellcome Global Health Trials (MR/M007405/1), Fogarty International Center (R21TW009982, D71TW010877), Grand Challenges Canada (0335-04), International Development Research Center Canada (IDRC 106887, 108167), Inter-American Institute for Global Change Research (IAI CRN3036), Medical Research Council (MR/P008984/1, MR/P024408/1, MR/P02386X/1), National Cancer Institute (1P20CA217231), National Heart, Lung and Blood Institute (HHSN268200900033C, 5U01HL114180, 1UM1HL134590), National Institute of Mental Health (1U19MH098780), Swiss National Science Foundation (40P740-160366), Wellcome (074833/Z/04/Z, 093541/Z/10/Z, 107435/Z/15/Z, 103994/Z/14/Z, 205177/Z/16/Z, 214185/Z/18/Z) and the World Diabetes Foundation (WDF15-1224).
Sources of information:
Directorio de Producción Científica
Scopus